Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk-stratified analysis of long-term clinical outcomes and cumulative costs in Finnish patients with recent acute coronary syndrome or coronary revascularization: a 5-year real-world study using electronic health records.
Oksanen M, Parviainen J, Asseburg C, Hageman S, Rissanen TT, Kivelä A, Taipale K, Visseren F, Martikainen J. Oksanen M, et al. Among authors: taipale k. Eur Heart J Open. 2024 Jun 18;4(4):oeae049. doi: 10.1093/ehjopen/oeae049. eCollection 2024 Jul. Eur Heart J Open. 2024. PMID: 38988674 Free PMC article.
Real-world evidence and patient preference for subcutaneous versus intravenous natalizumab in the treatment of relapsing-remitting multiple sclerosis - initial results from the observational SISTER study.
Gold R, Schmidt S, Deisenhammer F, Motte J, Richter N, Taipale K, Salmen HC, Bohland C, Schirduan K. Gold R, et al. Among authors: taipale k. Ther Adv Neurol Disord. 2024 Apr 13;17:17562864241241382. doi: 10.1177/17562864241241382. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 38616781 Free PMC article.
Pregnancy outcomes in female multiple sclerosis patients exposed to intramuscular interferon beta-1a or peginterferon beta-1a reported in a German Patient Support Programme - results from the non-interventional post-authorization safety study PRIMA.
Klehmet J, Begus-Nahrmann Y, Taipale K, Niemczyk G, Rehberg-Weber K. Klehmet J, et al. Among authors: taipale k. Ther Adv Neurol Disord. 2023 Dec 15;16:17562864231214041. doi: 10.1177/17562864231214041. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 38107443 Free PMC article.
Treatment Patterns, Clinical Outcomes and Health Care Resource Utilisation in Patients with EGFR-mutated Metastatic Non-Small Cell Lung Cancer: A Real-World Study in South Korea.
Molife C, Cho JM, Lapthorn J, Kang MJ, D'yachkova Y, Kim S, Colman S, Kim S, Szende A, Park JH, Ahn HK, Hong MH, Taipale KL, Kim HR. Molife C, et al. Among authors: taipale kl. Drugs Real World Outcomes. 2023 Mar;10(1):131-143. doi: 10.1007/s40801-022-00344-0. Epub 2022 Dec 2. Drugs Real World Outcomes. 2023. PMID: 36456850 Free PMC article.
Oncolytic adenovirus decreases the proportion of TIM-3+ subset of tumor-infiltrating CD8+ T cells with correlation to improved survival in patients with cancer.
Liikanen I, Basnet S, Quixabeira DCA, Taipale K, Hemminki O, Oksanen M, Kankainen M, Juhila J, Kanerva A, Joensuu T, Tähtinen S, Hemminki A. Liikanen I, et al. Among authors: taipale k. J Immunother Cancer. 2022 Feb;10(2):e003490. doi: 10.1136/jitc-2021-003490. J Immunother Cancer. 2022. PMID: 35193929 Free PMC article.
31 results